Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone Tablets

▴ Alembic Pharmaceuticals announces USFDA Final Approval for Metolazone Tablets
Metolazone Tablets are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class.

Alembic Pharmaceuticals Limited (Alembic) today announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Zaroxolyn Tablets 2.5 mg, 5 mg, and 1 O mg, of Lannett Company, Inc. Metolazone Tablets are indicated for the treatment of salt and water retention including: a) edema accompanying congestive heart failure; b) edema accompanying renal diseases, including the nephrotic syndrome and states of diminished renal function.

Metolazone Tablets are also indicated for the treatment of hypertension, alone or in combination with other antihypertensive drugs of a different class. Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg have an estimated market size of US$ 33 million for twelve months ending September 2020 according to IQVIA. Alembic has a cumulative total of 137 ANDA approvals (118 final approvals and 19 tentative approvals) from USFDA.

Tags : #LatestPharmaNewsDec3 #LatestAlembicNewsDec3 #TreatmentforHypertension

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

FTCCI with support from the Ministry of MSME, Govt of Inia to host an International Conference on Shipping and Logistics at HICC on 22nd MarchMarch 18, 2024
Rotary donates Upgraded Neonatal ICU at Niloufer Hospital worth Rs 48 LakhsMarch 18, 2024
Fateh Education shares insight into Financial strategies and Post-Study employment goals of students aspiring to study abroadMarch 18, 2024
Empowering Communities: We Care Foundation Hosts 3rd Edition of I - Inspiration Awards, Championing Health, Finance, and Cyber WellnessMarch 18, 2024
Safeguarding Spectators: Medulance Partners with Zomato Live for On-site Medical Assistance at ZomalandMarch 18, 2024
Unsung hero, Chindu Yakshaganam theatre artist, Padma Shri Gaddam Sammaiah graced the 17th Annual Day of Anurag UniversityMarch 18, 2024
Multidisciplinary Approach at Citizens Specialty Hospital Saved 35-year-old Patient with Disc Prolapse following a recent Heart AttackMarch 18, 2024
Asia Pacific region’s First Patellofemoral Joint surgery is successful in India.March 18, 2024
FDA Greenlights Lupin's Varenicline Tablets: A Game-Changer in Smoking Cessation TherapyMarch 18, 2024
Deciphering STAP-1: A Promising Target for Immune-Related DiseasesMarch 18, 2024
The Gut-Brain Connection: How Gut Bacteria Shape Immunity and Prevent Allergic Reactions in NewbornsMarch 18, 2024
IIIT Hyderabad’s Annual R&D Showcase beginsMarch 16, 2024
Exploring New Horizons: The Role of Copper and Resveratrol in Cancer CareMarch 16, 2024
Expanding Healthcare Infrastructure: Delhi’s Ambitious EndeavourMarch 16, 2024
FTCCI's Tourism Committee brands cab drivers as ambassadors for tourism and trains 200 cab drivers at GMR Airport in Etiquette, Hygiene, First Aid, CPR and the English languageMarch 16, 2024
Musing of a Teenage Girl, a poetry book authored by a 14 years girl Sanjana Somavarapu releasedMarch 16, 2024
5th Edition FTCCI HR Awards 2023 Presented for best practices in people processesMarch 15, 2024
FTCCI Delegation visits T-WorksMarch 15, 2024
Debunking Myths: ICMR Study Disproves COVID Vaccine Link to Sudden DeathsMarch 15, 2024
Beware of Rhodamine-B: Several States in India Implement Ban on Artificial Food Coloring AgentsMarch 15, 2024